Form 8-K - Current report:
SEC Accession No. 0001171843-19-002383
Filing Date
2019-04-12
Accepted
2019-04-12 16:05:12
Documents
5
Period of Report
2019-04-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_041219.htm 8-K 30600
2 EXHIBIT 10.1 exh_101.htm EX-10.1 35899
3 EXHIBIT 10.2 exh_102.htm EX-10.2 27337
4 EXHIBIT 10.3 exh_103.htm EX-10.3 70479
5 EXHIBIT 10.4 exh_104.htm EX-10.4 70369
  Complete submission text file 0001171843-19-002383.txt   236078
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

EIN.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 19746320
SIC: 3841 Surgical & Medical Instruments & Apparatus